Mercy BioAnalytics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
43
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$41M
- Investors
-
15
Mercy BioAnalytics General Information
Description
Developer of a novel liquid biopsy assay platform designed for the early detection of cancer. The company's platform interrogates tumor-derived extracellular vesicles, which are abundant in blood and carry information about their cell of origin, enabling patients to detect various types of cancer at the earliest stages.
Contact Information
Website
www.mercybio.comCorporate Office
- 22 Strathmore Road
- Suite 415
- Natick, MA 01760
- United States
Corporate Office
- 22 Strathmore Road
- Suite 415
- Natick, MA 01760
- United States
Mercy BioAnalytics Timeline
Mercy BioAnalytics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series A) | 13-Feb-2023 | $41M | Completed | Generating Revenue | ||
| 1. Seed Round | 29-Jan-2021 | Completed | Generating Revenue |
Mercy BioAnalytics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
Mercy BioAnalytics Comparisons
Industry
Financing
Details
Mercy BioAnalytics Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GRAIL | Formerly VC-backed | Menlo Park, CA |
Mercy BioAnalytics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Mercy BioAnalytics Patents
Mercy BioAnalytics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3238997-A1 | Compositions and methods for detection of ovarian cancer | Pending | 17-Nov-2021 | ||
| EP-4433827-A1 | Compositions and methods for detection of ovarian cancer | Pending | 17-Nov-2021 | ||
| CA-3227133-A1 | Compositions and methods for cancer detection | Pending | 21-Jul-2021 | ||
| CA-3227131-A1 | Compositions and methods for detection of prostate cancer | Pending | 21-Jul-2021 | ||
| CA-3227148-A1 | Compositions and methods for detection of colorectal cancer | Pending | 21-Jul-2021 | C12Q1/6886 |
Mercy BioAnalytics Executive Team (8)
| Name | Title | Board Seat |
|---|---|---|
| Dawn Mattoon | Chief Executive Officer & Board Member | |
| Tatia Troy | Chief People Officer | |
| Toumy Guettouche Ph.D | Chief Scientific Officer | |
| Paul Blavin | Co-Founder & Vice Chairman | |
| Diane Marcou | Consulting Chief Financial Officer |
Mercy BioAnalytics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Dawn Mattoon | Mercy BioAnalytics | Chief Executive Officer & Board Member | |
| Myla Lai-Goldman MD | Hatteras Venture Partners | Board Member | |
| Paul Blavin | Mercy BioAnalytics | Co-Founder & Vice Chairman | |
| Sonja Perkins | The Perkins Fund | Board Member | |
| Stanley Lapidus | Self | Chairman |
Mercy BioAnalytics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Mercy BioAnalytics Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AI Fund | Accelerator/Incubator | Minority | ||
| American Cancer Society | Corporation | Minority | ||
| BrightEdge | Impact Investing | Minority | ||
| Bruker | Corporation | Minority | ||
| Hatteras Venture Partners | Venture Capital | Minority |
Mercy BioAnalytics FAQs
-
When was Mercy BioAnalytics founded?
Mercy BioAnalytics was founded in 2018.
-
Who is the founder of Mercy BioAnalytics?
Joseph Sedlak Ph.D and Paul Blavin are the founders of Mercy BioAnalytics.
-
Who is the CEO of Mercy BioAnalytics?
Dawn Mattoon is the CEO of Mercy BioAnalytics.
-
Where is Mercy BioAnalytics headquartered?
Mercy BioAnalytics is headquartered in Natick, MA.
-
What is the size of Mercy BioAnalytics?
Mercy BioAnalytics has 43 total employees.
-
What industry is Mercy BioAnalytics in?
Mercy BioAnalytics’s primary industry is Diagnostic Equipment.
-
Is Mercy BioAnalytics a private or public company?
Mercy BioAnalytics is a Private company.
-
What is the current valuation of Mercy BioAnalytics?
The current valuation of Mercy BioAnalytics is .
-
What is Mercy BioAnalytics’s current revenue?
The current revenue for Mercy BioAnalytics is .
-
How much funding has Mercy BioAnalytics raised over time?
Mercy BioAnalytics has raised $68.3M.
-
Who are Mercy BioAnalytics’s investors?
AI Fund, American Cancer Society, BrightEdge, Bruker, and Hatteras Venture Partners are 5 of 15 investors who have invested in Mercy BioAnalytics.
-
Who are Mercy BioAnalytics’s competitors?
GRAIL is a competitor of Mercy BioAnalytics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
